Pamela J. Stahl

2016

In 2016, Pamela J. Stahl earned a total compensation of $1.7M as Chief Commercial Officer at InVivo Therapeutics Holdings.

Compensation breakdown

Bonus$465,962
Option Awards$1,020,056
Salary$92,202
Other$102,776
Total$1,680,996

Stahl received $1M in option awards, accounting for 61% of the total pay in 2016.

Stahl also received $466K in bonus, $92.2K in salary and $102.8K in other compensation.

Rankings

In 2016, Pamela J. Stahl's compensation ranked 5,700th out of 14,075 executives tracked by ExecPay. In other words, Stahl earned more than 59.5% of executives.

ClassificationRankingPercentile
All
5,700
out of 14,075
60th
Division
Manufacturing
2,067
out of 5,489
62nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
282
out of 827
66th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
151
out of 510
70th
Industry
Surgical and Medical Instruments and Apparatus
81
out of 313
74th
Source: SEC filing on April 25, 2017.

Stahl's colleagues

We found six more compensation records of executives who worked with Pamela J. Stahl at InVivo Therapeutics Holdings in 2016.

2016

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2016

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2016

Thomas Ulich

InVivo Therapeutics Holdings

Chief Scientific Officer

2016

Lorianne Masuoka

InVivo Therapeutics Holdings

Chief Medical Officer

2016

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

2016

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

News

In-depth

You may also like